Focusing on SAT, our results showed an increase of SFRP5 mRNA expression in NASH group compared with NL (Figure 5A,B, this last one disaggregating the stage of SS into mild and moderate/severe (mod/sev)). This evidence concerns the gene SFRP5 and metabolic dysfunction-associated steatohepatitis.